F2 Medical Supplies Ltd - Period Ending 2019-03-31

F2 Medical Supplies Ltd - Period Ending 2019-03-31


F2 Medical Supplies Ltd 07992460 false 2018-04-01 2019-03-31 2019-03-31 The principal activity of the company is the supply of medical goods Digita Accounts Production Advanced 6.24.8820.0 Software true 07992460 2018-04-01 2019-03-31 07992460 2019-03-31 07992460 bus:OrdinaryShareClass1 2019-03-31 07992460 core:CurrentFinancialInstruments 2019-03-31 07992460 core:CurrentFinancialInstruments core:WithinOneYear 2019-03-31 07992460 core:Non-currentFinancialInstruments 2019-03-31 07992460 core:Non-currentFinancialInstruments core:AfterOneYear 2019-03-31 07992460 core:FurnitureFittingsToolsEquipment 2019-03-31 07992460 core:LandBuildings 2019-03-31 07992460 core:OtherPropertyPlantEquipment 2019-03-31 07992460 bus:SmallEntities 2018-04-01 2019-03-31 07992460 bus:AuditExemptWithAccountantsReport 2018-04-01 2019-03-31 07992460 bus:FullAccounts 2018-04-01 2019-03-31 07992460 bus:SmallCompaniesRegimeForAccounts 2018-04-01 2019-03-31 07992460 bus:RegisteredOffice 2018-04-01 2019-03-31 07992460 bus:Director1 2018-04-01 2019-03-31 07992460 bus:Director2 2018-04-01 2019-03-31 07992460 bus:OrdinaryShareClass1 2018-04-01 2019-03-31 07992460 bus:PrivateLimitedCompanyLtd 2018-04-01 2019-03-31 07992460 core:Buildings 2018-04-01 2019-03-31 07992460 core:FurnitureFittings 2018-04-01 2019-03-31 07992460 core:FurnitureFittingsToolsEquipment 2018-04-01 2019-03-31 07992460 core:Land 2018-04-01 2019-03-31 07992460 core:LandBuildings 2018-04-01 2019-03-31 07992460 core:OtherPropertyPlantEquipment 2018-04-01 2019-03-31 07992460 countries:UnitedKingdom 2018-04-01 2019-03-31 07992460 2018-03-31 07992460 core:FurnitureFittingsToolsEquipment 2018-03-31 07992460 core:LandBuildings 2018-03-31 07992460 core:OtherPropertyPlantEquipment 2018-03-31 07992460 2017-04-01 2018-03-31 07992460 2018-03-31 07992460 bus:OrdinaryShareClass1 2018-03-31 07992460 core:CurrentFinancialInstruments 2018-03-31 07992460 core:CurrentFinancialInstruments core:WithinOneYear 2018-03-31 07992460 core:Non-currentFinancialInstruments 2018-03-31 07992460 core:Non-currentFinancialInstruments core:AfterOneYear 2018-03-31 07992460 core:FurnitureFittingsToolsEquipment 2018-03-31 07992460 core:LandBuildings 2018-03-31 07992460 core:OtherPropertyPlantEquipment 2018-03-31 07992460 bus:OrdinaryShareClass1 2017-04-01 2018-03-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 07992460

F2 Medical Supplies Ltd

Annual Report and Unaudited Financial Statements

for the Year Ended 31 March 2019

John R Reeds FCA
48 St Peters Road
Buxton
Derbyshire
SK17 7DX


 

 

F2 Medical Supplies Ltd

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Unaudited Financial Statements

4 to 9

 

F2 Medical Supplies Ltd

Company Information

Directors

Mr Arun Sarna

Mr Arvind Sarna

Registered office

11 Midland Street
LEICESTER
LE1 1TG

Accountants

John R Reeds FCA
48 St Peters Road
Buxton
Derbyshire
SK17 7DX

 

F2 Medical Supplies Ltd

(Registration number: 07992460)
Balance Sheet as at 31 March 2019

Note

2019
£

2018
£

Fixed assets

 

Tangible assets

4

259,894

259,750

Current assets

 

Stocks

5

210,717

178,126

Debtors

6

296,643

271,595

Cash at bank and in hand

 

326,217

196,816

 

833,577

646,537

Creditors: Amounts falling due within one year

7

(317,354)

(253,244)

Net current assets

 

516,223

393,293

Total assets less current liabilities

 

776,117

653,043

Creditors: Amounts falling due after more than one year

7

(285,982)

(339,367)

Net assets

 

490,135

313,676

Capital and reserves

 

Called up share capital

8

2

2

Profit and loss account

490,133

313,674

Total equity

 

490,135

313,676

For the financial year ending 31 March 2019 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

Approved and authorised by the Board on 6 December 2019 and signed on its behalf by:
 

 

F2 Medical Supplies Ltd

(Registration number: 07992460)
Balance Sheet as at 31 March 2019

.........................................

Mr Arun Sarna
Director

.........................................

Mr Arvind Sarna
Director

 

F2 Medical Supplies Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2019

1

General information

The company is a private company limited by share capital, incorporated in United Kingdom.

The address of its registered office is:
11 Midland Street
LEICESTER
LE1 1TG
United Kingdom

These financial statements were authorised for issue by the Board on 6 December 2019.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

 

F2 Medical Supplies Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2019

Tangible assets

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Freehold Land and Buildings

Land - Not Depreciated

Freehold Land and Buildings

Buildings - 2% Straight Line

Fixtures and Fittings

33% Straight Line

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

 

F2 Medical Supplies Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2019

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the Profit and Loss Account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 3 (2018 - 2).

 

F2 Medical Supplies Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2019

4

Tangible assets

Land and buildings
£

Furniture, fittings and equipment
 £

Other tangible assets
£

Total
£

Cost or valuation

At 1 April 2018

260,250

1,583

-

261,833

Additions

-

588

-

588

At 31 March 2019

260,250

2,171

-

262,421

Depreciation

At 1 April 2018

500

1,583

-

2,083

Charge for the year

250

578

(384)

444

At 31 March 2019

750

2,161

(384)

2,527

Carrying amount

At 31 March 2019

259,500

10

384

259,894

At 31 March 2018

259,750

-

-

259,750

Included within the net book value of land and buildings above is £259,500 (2018 - £259,750) in respect of freehold land and buildings.
 

5

Stocks

2019
£

2018
£

Other inventories

210,717

178,126

6

Debtors

Note

2019
£

2018
£

Trade debtors

 

181,523

155,837

Amounts owed by group undertakings and undertakings in which the company has a participating interest

11

102,883

102,883

Other debtors

 

12,237

12,875

 

296,643

271,595

 

F2 Medical Supplies Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2019

7

Creditors

Creditors: amounts falling due within one year

Note

2019
£

2018
£

Due within one year

 

Loans and borrowings

9

31,914

59,437

Trade creditors

 

88,828

76,303

Amounts owed to group undertakings and undertakings in which the company has a participating interest

11

15,004

15,004

Taxation and social security

 

165,649

101,939

Accruals and deferred income

 

15,959

561

 

317,354

253,244

Creditors: amounts falling due after more than one year

Note

2019
£

2018
£

Due after one year

 

Loans and borrowings

9

285,982

339,367

8

Share capital

Allotted, called up and fully paid shares

 

2019

2018

 

No.

£

No.

£

Ordinary of £1 each

2

2

2

2

         

9

Loans and borrowings

2019
£

2018
£

Non-current loans and borrowings

Bank borrowings

285,982

339,367

 

F2 Medical Supplies Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2019

2019
£

2018
£

Current loans and borrowings

Bank borrowings

28,668

56,191

Other borrowings

3,246

3,246

31,914

59,437

10

Dividends

   

2019

 

2018

   

£

 

£

Interim dividend of £144,000.00 (2018 - £72,000.00) per ordinary share

 

144,000

 

72,000

         

Interim dividends paid

   

2019
£

 

2018
£

Interim dividend of £720 per each Ordinary

 

144,000

 

72,000

         

11

Related party transactions

Directors' remuneration

The directors' remuneration for the year was as follows:

2019
£

2018
£

Remuneration

8,400

8,860